London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Toric ICL V4c® in the correction of myopia and astigmatism: efficacy, predictability and safety

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Posterior chamber Phakic IOLS for correction of Myopia

Session Date/Time: Monday 15/09/2014 | 08:00-10:30

Paper Time: 08:47

Venue: Capital Hall B

First Author: : R.Massa PORTUGAL

Co Author(s): :    I. Casal   M. Lume   R. Salgado   M. Brochado     

Abstract Details

Purpose:

To analyze the efficacy, predictability and safety of a posterior chamber phakic intraocular lens -Toric ICL v4c®- in patients with moderate to high myopia and astigmatism.

Setting:

Ophthalmology Department of Centro Hospitalar do Porto – Hospital de Santo António in Oporto, Portugal.

Methods:

We reviewed the clinical files including ophthalmological evaluations complemented with ancillary exams such as Orbscan®, Pentacam ®, specular miscroscopy and ultrasound biomicroscopy of 15 patients (19 eyes) who underwent an implantation of a Toric ICL v4c®. The mean age was 32.4 +/- 5.6 years (varying from 24 to 41 years old). Mean horizontal corneal diameter evaluated by Orbscan® was 11.85 mm (varying from 11.4 to 12.8 mm) and mean anterior chamber depth was 3.12 +/-0.28mm. Emmetropia was the target postoperative spherical equivalent refraction. Mean “follow-up” was 12 months (varying from 4 to 20 months). Statistical analysis was performed with SPSS version 20.0.

Results:

Mean preoperative intraocular pressure (IOP) was 12+/-2 mmHg with an increase of 0.08+/-0.30 mmHg postoperatively (p=0.23).Mean preoperative endotelial cell count was 2969 cells/mm2 (from 2398 to 3731 cells/mm2) with a reduction of 170+/-70 cells/mm2 postoperatively (p=0.10). Mean of preoperative best corrected visual acuity (BCVA) was 0.21 +/- 0.19 log MAR with an increase to a mean postoperative BCVA of 0.11+/-0.12 logMAR (p=0.00) Mean preoperative astigmatism was -2.47+/-0.87 D with a decrease to -0.58+/-0.74 D postoperatively (p=0.00). Mean preoperative spherical equivalent was -9.37 +/- 4.21 D and decreased to -0.26+/-0.48 D (p=0.00) postoperatively with 60% of eyes within +/-0.50D of emmetropia. Mean preoperative anterior chamber angle was 36.3+/-3.05° (varying from 29.3 to 41.4°) with a change to 23.9+/-4.12° (from 18.8 to 32.4°) postoperatively (p=0.00). Mean vault was 295 +/-154 µm (from 100 to 500 µm). Complications such as ocular hypertension/glaucoma and cataract were not verified in these patients.

Conclusions:

Posterior chamber phakic lens Toric ICL v4c is effective , predictable and safe in the correction of moderate to high myopia and astigmatism. Developments in the determination of its size may already improve its characteristics.

Financial Interest:

NONE

Back to previous